Biotage AB (publ)
OM-BIOT
Company Overview
Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Name
Biotage AB (publ)
CEO
Mr. Torben Jorgensen B.Sc.
Website
www.biotage.com
Sector
Life Sciences Tools and Services
Year Founded
1969
Profile
Market Cap
SEK 14.83B
EV
SEK 14.76B
Shares Out
80.05M
Revenue
SEK 2,077M
Employees
667
Margins
Gross
62.73%
EBITDA
23.5%
Operating
17.86%
Pre-Tax
15.07%
Net
12.08%
FCF
16.42%
Returns (5Yr Avg)
ROA
11.27%
ROTA
19.07%
ROE
16.29%
ROCE
15.97%
ROIC
14.15%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
SEK 191
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
SEK 318M
Net Debt
-SEK 64M
Debt/Equity
0.07
EBIT/Interest
9.05
Growth (CAGR)
Rev 3Yr
21.94%
Rev 5Yr
15.81%
Rev 10Yr
16.29%
Dil EPS 3Yr
3.01%
Dil EPS 5Yr
3.33%
Dil EPS 10Yr
15.57%
Rev Fwd 2Yr
13.92%
EBITDA Fwd 2Yr
13.7%
EPS Fwd 2Yr
16.46%
EPS LT Growth Est
19.6%
Dividends
Yield
—
Payout
51%
DPS
SEK 1.6
DPS Growth 3Yr
2.17%
DPS Growth 5Yr
1.3%
DPS Growth 10Yr
10.31%
DPS Growth Fwd 2Yr
14.38%